Revance’s $260 Million China Market License Agreement with Fosun Pharma for RT002

O’Melveny represented Silicon Valley-based biotechnology company Revance Therapeutics, Inc. in a licensing agreement with Shanghai Fosun Pharmaceutical Industrial Development Co. Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Impact Electrons Siam Co., Ltd.’s Joint Venture Arrangements to Raise Additional Capital for Solar Project Developments

Hunton Andrews Kurth (Thailand) Limited represented Impact Electrons Siam Company Limited (IES), an innovative energy company, which together with its affiliated companies, is developing more than...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

PGLH of Delaware, Inc.’s Acquisition of Dewan Housing Finance Corporation’s Interest in DHFL Pramerica Asset Managers Private Limited and DHFL Pramerica Trustees Private Limited

Khaitan & Co advised Dewan Housing Finance Corporation Limited (DHFL) on the deal Dewan Housing Finance Corporation Limited (DHFL) executed its disinvestment of the entire stake...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here